MDCE / Medical Care Technologies Inc. - Pemfailan SEC, Laporan Tahunan, Penyata Proksi

Medical Care Technologies Inc.
US ˙ OTCPK

Statistik Asas
CIK 1404593
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Medical Care Technologies Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
July 11, 2025 253G2

SUPPLEMENT NO. 2 DATED JULY 10, 2025 TO OFFERING CIRCULAR DATED APRIL 10, 2025

Supplement filed pursuant to Rule 253(g)(2) File No. 024-12484 SUPPLEMENT NO. 2 DATED JULY 10, 2025 TO OFFERING CIRCULAR DATED APRIL 10, 2025 This document supplements, and should be read in conjunction with, the offering circular (the “Offering Circular”) dated April 10, 2025 of Medical Care Technologies, Inc. (the “Company”). Unless otherwise defined in this supplement, capitalized terms used in

July 3, 2025 253G2

MEDICAL CARE TECHNOLOGIES, INC. a Nevada Corporation 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 Up to 2,000,000,000 Shares of Common Stock

Supplement filed pursuant to Rule 253(g)(2) File No. 024-12484 This document supplements, and should be read in conjunction with, the offering circular (the “Offering Circular”) dated April 10, 2025 of Medical Care Technologies, Inc. (the “Company”). Unless otherwise defined in this supplement, capitalized terms used in this supplement shall have the same meanings as set forth in the Offering Circ

April 10, 2025 PART II AND III

PRELIMINARY OFFERING CIRCULAR, POST-QUALIFICATION AMENDMENT NO. 3 SUBJECT TO COMPLETION MEDICAL CARE TECHNOLOGIES, INC. a Nevada Corporation 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 Up to 2,000,000,000 Shares of Common Stock

Post-Qualification Offering Circular Amendment No. 3 File No. 024-12484 PRELIMINARY OFFERING CIRCULAR, POST-QUALIFICATION AMENDMENT NO. 3 SUBJECT TO COMPLETION MEDICAL CARE TECHNOLOGIES, INC. a Nevada Corporation 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 Up to 2,000,000,000 Shares of Common Stock This Post-Qualification Offering Circular Amendment No. 1 (the “PQA”) amends the Offering Circular

April 10, 2025 EX1A-12 OPN CNSL

April 9, 2025

Exhibit 12.1 18305 BISCAYNE BLVD. SUITE 200 JONATHAN D. LEINWAND, P.A. AVENTURA, FL 33160 TEL: (954) 903-7856 FAX: (954) 252-4265 E-MAIL: [email protected] April 9, 2025 Medical Care Technologies Inc. 1910 S. Stapley Drive, Suite 221 Mesa, AZ 85204 Ladies and Gentlemen: We are acting as counsel to Medical Care Technologies Inc., a Nevada corporation (“MDCE”), for the purpose of rendering an opini

March 27, 2025 PART II AND III

PRELIMINARY OFFERING CIRCULAR, POST-QUALIFICATION AMENDMENT NO. 2 SUBJECT TO COMPLETION MEDICAL CARE TECHNOLOGIES, INC. a Nevada Corporation 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 Up to 2,000,000,000 Shares of Common Stock

Post-Qualification Offering Circular Amendment No. 2 File No. 024-12484 PRELIMINARY OFFERING CIRCULAR, POST-QUALIFICATION AMENDMENT NO. 2 SUBJECT TO COMPLETION MEDICAL CARE TECHNOLOGIES, INC. a Nevada Corporation 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 Up to 2,000,000,000 Shares of Common Stock This Post-Qualification Offering Circular Amendment No. 1 (the “PQA”) amends the Offering Circular

March 14, 2025 PART II AND III

PRELIMINARY OFFERING CIRCULAR, POST-QUALIFICATION AMENDMENT NO. 1 SUBJECT TO COMPLETION MEDICAL CARE TECHNOLOGIES, INC. a Nevada Corporation 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 Up to 2,000,000,000 Shares of Common Stock

Post-Qualification Offering Circular Amendment No. 1 File No. 024-12484 PRELIMINARY OFFERING CIRCULAR, POST-QUALIFICATION AMENDMENT NO. 1 SUBJECT TO COMPLETION MEDICAL CARE TECHNOLOGIES, INC. a Nevada Corporation 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 Up to 2,000,000,000 Shares of Common Stock This Post-Qualification Offering Circular Amendment No. 1 (the “PQA”) amends the Offering Circular

January 3, 2025 253G2

MEDICAL CARE TECHNOLOGIES, INC. a Nevada Corporation 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 SUPPLEMENT NO. 1 DATED JANUARY 3, 2025

Filed pursuant to Rule 253(g)(2) File No. 024-12484 MEDICAL CARE TECHNOLOGIES, INC. a Nevada Corporation 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 SUPPLEMENT NO. 1 DATED JANUARY 3, 2025 This document supplements, and should be read in conjunction with, the offering circular of Medical Care Technology Inc. (the “Company”), filed with the Securities and Exchange Commission (the “SEC”) pursuant t

December 6, 2024 253G1

MEDICAL CARE TECHNOLOGIES, INC. a Nevada Corporation 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 Up to 2,000,000,000 Shares of Common Stock

Filed pursuant to Rule 253(g)(1) File No. 024-12484 MEDICAL CARE TECHNOLOGIES, INC. a Nevada Corporation 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 Up to 2,000,000,000 Shares of Common Stock Medical Care Technologies Inc., a Nevada corporation (the “Company” or “MDCE”) is offering investors (the “Offering”) the opportunity to purchase MDCE common shares (the “Shares”). The Shares will be sold a

December 4, 2024 CORRESP

Medical Care Technologies Inc. 1910 S Stapley Drive Suite 221 Mesa, AZ 85204

Medical Care Technologies Inc. 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 December 4, 2024 Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Medical Care Technologies Inc. Offering Statement on Form 1-A Filed August 9, 2024 File No. 024-12484 To the Staff, This letter sets forth the request of Medical Care Technologies

November 26, 2024 PART II AND III

PART II — OFFERING CIRCULAR

PART II — OFFERING CIRCULAR An Offering Circular pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission.

September 6, 2024 PART II AND III

PART II — OFFERING CIRCULAR

PART II — OFFERING CIRCULAR An Offering Circular pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission.

September 6, 2024 CORRESP

September 6, 2024

18305 Biscayne Blvd. SUITE 200 JONATHAN D. LEINWAND, P.A. AVENTURA, FL 33160 TEL: (954) 903-7856 FAX: (954) 252-4265 E-MAIL: [email protected] September 6, 2024 US Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services Washington, D.C. 20549 Re: Medical Care Technologies Inc. Offering Statement on Form 1-A Filed August 9, 2024 File No. 024-12484 Ladies and G

August 9, 2024 EX1A-4 SUBS AGMT

MEDICAL CARE TECHNOLOGIES INC. SUBSCRIPTION AGREEMENT NOTICE TO INVESTORS

Exhibit 4.1 MEDICAL CARE TECHNOLOGIES INC. SUBSCRIPTION AGREEMENT NOTICE TO INVESTORS THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE

August 9, 2024 PART II AND III

PART II — OFFERING CIRCULAR

PART II — OFFERING CIRCULAR An Offering Circular pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission.

August 9, 2024 EX1A-2B BYLAWS

AMENDED AND RESTATED BYLAWS Medical Care Technologies Inc.

Exhibit 2.2 AMENDED AND RESTATED BYLAWS OF Medical Care Technologies Inc. I. SHAREHOLDER'S MEETING. .01 Annual Meetings. The annual meeting of the shareholders of this Corporation, for the purpose of election of Directors and for such other business as may come before it, shall be held at the registered office of the Corporation, or such other places, either within or without the State of Nevada,

August 9, 2024 EX1A-2A CHARTER

ARTICLES OF INCORPORATION

Exhibit 2.1

August 9, 2024 EX1A-12 OPN CNSL

August 8, 2024

Exhibit 12.1 18305 BISCAYNE BLVD. SUITE 200 JONATHAN D. LEINWAND, P.A. AVENTURA, FL 33160 TEL: (954) 903-7856 FAX: (954) 252-4265 E-MAIL: [email protected] August 8, 2024 Medical Care Technologies Inc. 1910 S. Stapley Drive, Suite 221 Mesa, AZ 85204 Ladies and Gentlemen: We are acting as counsel to Medical Care Technologies Inc., a Nevada corporation (“MDCE”), for the purpose of rendering an opin

May 8, 2013 15-12G

- FORM 15-12G NOTICE OF TERMINATION

FORM 15-12G Notice of Termination UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

April 2, 2013 NT 10-K

- ANNUAL REPORT EXTENSION

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 Commission File Number 000-53665 CUSIP Number: 584507107 NOTIFICATION OF LATE FILING (Check One) x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2012 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form 20-F ¨ Transition Report on Form N-SAR ¨ Transition Report on Form 11-K For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form.

December 3, 2012 SC 13D/A

MDCE / Medical Care Technologies Inc. / AGS CAPITAL GROUP LLC - SCHEDULE 13D AMENDMENT NO. 1 Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under The Securities Exchange Act of 1934 (Amendment No 1) MEDICAL CARE TECHNOLOGIES, INC. (Name of Issuer) Common Stock, $0.00001 Per Share (Title of Class of Securities) 584507107 (CUSIP Number) AGS Capital Group, LLC Attn: Allen Silberstein 801 Brickell Avenue, Suite 902 Miami, FL 33131 (305) 789-6641 (Name, Ad

November 20, 2012 EX-99.1

MEDICAL CARE TECHNOLOGIES INC. ISSUES CEO LETTER TO SHAREHOLDERS

Exhibit 99.1 FOR IMMEDIATE RELEASE MEDICAL CARE TECHNOLOGIES INC. ISSUES CEO LETTER TO SHAREHOLDERS Promising future for pediatric healthcare in China BEIJING, CHINA – November 20, 2012 – Medical Care Technologies Inc. (OTCBB: MDCE), a growing American company providing children’s healthcare services and western healthcare products distribution in China, released today the following letter to shar

November 20, 2012 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 20, 2012 Medical Care Technologies Inc.

November 19, 2012 10-Q

Quarterly Report - QUARTERLY REPORT

f10q0912medicalcare.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC.

November 15, 2012 NT 10-Q

- NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53665 CUSIP NUMBER 584507107 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended September 30, 2012 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Tra

October 17, 2012 SC 13D

MDCE / Medical Care Technologies Inc. / AGS CAPITAL GROUP LLC - SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under The Securities Exchange Act of 1934 (Amendment No *) MEDICAL CARE TECHNOLOGIES, INC. (Name of Issuer) Common Stock, $0.00001 Per Share (Title of Class of Securities) 584507107 (CUSIP Number) AGS Capital Group, LLC Attn: Allen Silberstein 801 Brickell Avenue, Suite 902 Miami, FL 33131 (305) 789-6641 (Name, Ad

October 12, 2012 EX-10.58

MEDICAL CARE TECHNOLOGIES INC. EXECUTIVE OFFICER EMPLOYMENT AGREEMENT

EX-10.58 2 f8k100812ex10lviiimedical.htm EXECUTIVE OFFICER EMPLOYMENT AGREEMENT DATED OCTOBER 8, 2012 BETWEEN MEDICAL CARE TECHNOLOGIES INC. AND THOMAS J. (JOE) HALL II Exhibit 10.58 MEDICAL CARE TECHNOLOGIES INC. EXECUTIVE OFFICER EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (the "Agreement") is made between MEDICAL CARE TECHNOLOGIES INC. , a Nevada corporation (the "Company") located

October 12, 2012 SC 13G

MDCE / Medical Care Technologies Inc. / AGS CAPITAL GROUP LLC - SCHEDULE 13G Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* MEDICAL CARE TECHNOLOGIES, INC. (Name of Issuer) COMMON STOCK, $0.00001 PER SHARE (Title of Class of Securities) 584507107 (CUSIP Number) April 5, 2012 (Date of Event Which Requires Filing of this Statement) CUSIP No. 584507107 Page 1 of 6 Pages 1 NAMES OF REPORTING PE

October 12, 2012 EX-99.1

MEDICAL CARE TECHNOLOGIES INC. ANNOUNCES DYNAMIC LEADERSHIP CHANGES IN THE LEAD UP TO THE OPENING OF ITS FIRST CHILDREN’S HEALTH CENTER IN CHINA -The right people in the right places…as the Shenzhen center moves closer to becoming China’s first, priv

Exhibit 99.1 FOR IMMEDIATE RELEASE MEDICAL CARE TECHNOLOGIES INC. ANNOUNCES DYNAMIC LEADERSHIP CHANGES IN THE LEAD UP TO THE OPENING OF ITS FIRST CHILDREN’S HEALTH CENTER IN CHINA -The right people in the right places…as the Shenzhen center moves closer to becoming China’s first, private, western-style pediatric health facility BEIJING, CHINA – October 12, 2012 – Medical Care Technologies Inc. (OT

October 12, 2012 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 8, 2012 MEDICAL CARE TECHNOLOGIES INC.

September 21, 2012 S-8

- FORM S-8

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDICAL CARE TECHNOLOGIES INC.

September 21, 2012 EX-10.56

Article I

EXHIBIT 10.56 Agreement Agreement, made as of April 23,2012 between Medical Care Technologies Inc. (the "Corporation"), and David Lubin, Esq. (the "Consultant"). Whereas, the Corporation wishes to issue the Consultant the number of shares of common stock provided for herein for services previously provided by the Consultant to the Corporation, and the Consultant is willing to accept the shares und

September 21, 2012 EX-10.54

BUSINESS ADVISORY & CONSULTING AGREEMENT

EXHIBIT 10.54 BUSINESS ADVISORY & CONSULTING AGREEMENT This Agreement is entered into and with effective date the 1st day of April 2012 by and between Medical Care Technologies Inc. (the "Company") and Antoinette McMurray-Nelson (the "Consultant"), (hereinafter referred to collectively as the "Parties"). WHEREAS the Company desires to be assured of the association and services of the Consultant in

September 21, 2012 EX-10.55

ADMINISTRATIVE AND SUPPORT SERVICES AGREEMENT

EXHIBIT 10.55 ADMINISTRATIVE AND SUPPORT SERVICES AGREEMENT This Administrative and Support Services Agreement is entered into by and between Margaret Yuen Yuen Chang (“Consultant”) with her headquarters in Hong Kong and Medical Care Technologies Inc., with its headquarters in Beijing, China (“Company”). RECITALS WHEREAS, the Consultant has the office premises and office staff required to provide

September 21, 2012 EX-10.57

NEW ENGINEERING SERVICES AGREEMENT

EXHIBIT 10.57 NEW ENGINEERING SERVICES AGREEMENT THIS AGREEMENT made effective May 1st, 2012 (the "Effective Date"). BETWEEN: MEDICAL CARE TECHNOLOGIES INC., a body corporate, incorporated pursuant to the laws of the State of Nevada, U. S. A. (hereinafter referred to as the "Corporation") OF THE FIRST PART - and - BARRY P.N. TSAI, a resident of the city of Toronto, in the Province of Ontario, Cana

September 21, 2012 EX-3.1

1

EXHIBIT 3.1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

September 21, 2012 EX-10.53

JKMOY: Justin K. MOY Room 815, No. 2 Building Beixiaojie Dongzhimen Nei, Beijing China 10009 MDCE: Medical Care Technologies, Inc. Room 815, No. 2 Building Beixiaojie Dongzhimen Nei, Beijing China 10009

EXHIBIT 10.53 DG, CHINA NEW ADMINISTRATIVE SERVICES AGREEMENT (the "Agreement") dated as of April 1, 2012 between Medical Care Technologies Inc., a Nevada corporation ("MDCE") and Justin K. MOY ("JKMOY"), an individual. For good and valuable consideration, the receipt and legal sufficiency of which are hereby expressly acknowledged, the parties hereto agree as follows: 1. Engagement. Upon the term

September 21, 2012 EX-4.2

EX-4.2

EXHIBIT 4.2

September 14, 2012 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 12, 2012 MEDICAL CARE TECHNOLOGIES INC.

August 17, 2012 EX-10.52

Principal Amount: $35,000.00 Issue Date: August 13th , 2012 CONVERTIBLE PROMISSORY NOTE

Exhibit 10.52 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR

August 17, 2012 10-Q

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant as

August 14, 2012 NT 10-Q

- NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53665 NOTIFICATION OF LATE FILING CUSIP NUMBER 584507107 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period EndedJune 30, 2012 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transitio

July 30, 2012 10-Q/A

Quarterly Report - FORM 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 2) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2012 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES

July 27, 2012 EX-10.50

PURCHASE AND ASSIGNMENT AGREEMENT

EXHIBIT 10.50 PURCHASE AND ASSIGNMENT AGREEMENT THIS PURCHASE AND ASSIGNMENT AGREEMENT (this “Agreement”), is entered into on July 17, 2012, by and between Barry Tsai (the “Assignor”) and Light Hammer, LLC (the “Assignee”). WHEREAS, Assignor is the legal and beneficial owner of that certain promissory note dated March 6, 2012, in the amount of $10,000 (the “Promissory Note”) and due on March 5, 20

July 27, 2012 EX-10.49

CONVERTIBLE PROMISSORY NOTE

EXHIBIT 10.49 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR

July 27, 2012 8-K

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 12, 2012 MEDICAL CARE TECHNOLOGIES INC.

July 27, 2012 EX-10.48

SECURITIES SALE AGREEMENT

EXHIBIT 10.48 SECURITIES SALE AGREEMENT THIS SECURITIES SALE AGREEMENT, dated as of July 17, 2012 (this "Agreement"), by and between Nicola SUPPA, an individual ("Buyer"), and Medical Care Technologies Inc., a Nevada corporation (“Seller”). Pursuant to and in reliance upon the exemption from registration by the Securities and Exchange Commission ("SEC") under the Securities Act of 1933, as amended

July 27, 2012 EX-10.47

LOAN AGREEMENT

EX-10.47 2 mdceex1047.htm LOAN AGREEMENT EXHIBIT 10.47 LOAN AGREEMENT THIS LOAN AGREEMENT, dated June 12th, 2012, made in Hong Kong, by and between: Party A: Ocean Wise International Industrial Limited, a Hong Kong incorporated company, with address at: 1301 Bank of America Tower, 12 Harcourt Road, Central Hong Kong. Party B: Medical Care Technologies Inc., a Nevada, USA incorporated company, with

July 27, 2012 EX-10.51

PURCHASE AND ASSIGNMENT AGREEMENT

Exhibit 10.51 PURCHASE AND ASSIGNMENT AGREEMENT THIS PURCHASE AND ASSIGNMENT AGREEMENT (this “Agreement”), is entered into on July 17, 2012, by and between Boris Matsokhin (the “Assignor”) and Light Hammer, LLC (the “Assignee”). WHEREAS, Assignor is the legal and beneficial owner of that certain promissory note dated March 8, 2012, in the amount of $5,000 (the “Promissory Note”) and due on March 7

July 17, 2012 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 29, 2012 MEDICAL CARE TECHNOLOGIES INC.

July 17, 2012 EX-10.37

U.S. Securities and Exchange Commission

EXHIBIT 10.37 U.S. Securities and Exchange Commission 450 Fifth Street, N.W. Washington, DC 20549 RE: Medical Care Technologies Inc. We agree with the Company’s statements regarding the discovery and reporting of errors in previously issued financial statements. We are also in agreement with management’s intentions regarding the restatements discussed in this Form 8-k. /s/ MaloneBailey, LLP www.ma

July 17, 2012 EX-10.45

NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES A

EXHIBIT 10.45 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION

July 17, 2012 EX-10.46

MEDICAL CARE TECHNOLOGIES INC. Amended and Restated 10% Convertible Debenture Due November 29, 2014

EXHIBIT 10.46 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION

July 17, 2012 EX-10.36

Medical Care Technologies Inc. Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei, Beijing, People's Republic of China Website: www.medicaretechinc.com Tel: (8610) 6407 0580 May 29, 2012

EX-10.36 2 mdceex1036.htm IRREVOCABLE TRANSFER AGENT INSTRUCTIONS EXHIBIT 10.36 Medical Care Technologies Inc. Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei, Beijing, People's Republic of China Website: www.medicaretechinc.com Tel: (8610) 6407 0580 May 29, 2012 Manhattan Transfer Registrar Co. 57 Eastwood Road Miller Place, NY 11764 Ladies and Gentlemen: MEDICAL CARE TECHNOLOGIES INC., a Nev

May 25, 2012 EX-10.42

MEDICAL CARE TECHNOLOGIES, INC.

EXHIBIT 10.42 Exhibit A. MEDICAL CARE TECHNOLOGIES, INC. $25,000 TWELVE PERCENT (12%) CONVERTIBLE NOTE DATED MAY 21, 2012 THIS NOTE (the “Note”) is a duly authorized Convertible Note of MEDICAL CARE TECHNOLOGIES, INC., a NEVADA corporation (the “Company”). FOR VALUE RECEIVED, the Company promises to pay Atlas Equity Offshore, Ltd (the “Holder”), the principal sum of $25,000 (the “Principal Amount”

May 25, 2012 EX-10.43

ASSIGNMENT AND MODIFICATION AGREEMENT

EXHIBIT 10.43 ASSIGNMENT AND MODIFICATION AGREEMENT This assignment and modification agreement (the "Agreement") is made by and among MEDICAL CARE TECHNOLOGIES, INC. (the "Issuer"), C. Wang (the "Non Affiliate Debtholder") and Atlas Equity Offshore, Ltd (the "Investor"), on May 21, 2012. (The Issuer, the Non Affiliate Debtholder and the Investor are sometimes referred to in this Agreement singly a

May 25, 2012 EX-10.44

MEDICAL CARE TECHNOLOGIES, INC. May 21, 2012

EX-10.44 4 mdceex1044.htm IRREVOCABLE TRANSFER AGENT INSTRUCTIONS FROM MEDICAL CARE TECHNOLOGIES, INC. TO MANHATTAN TRANSFER REGISTRAR CO. EXHIBIT 10.44 MEDICAL CARE TECHNOLOGIES, INC. May 21, 2012 Manhattan Transfer Registrar Co. 57 Eastwood Road Miller Place, NY 11764 Ladies and Gentlemen: MEDICAL CARE TECHNOLOGIES, INC., a NEVADA corporation (the "Company") and Atlas Equity Offshore, Ltd (the "

May 25, 2012 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 21, 2012 MEDICAL CARE TECHNOLOGIES INC.

May 24, 2012 10-Q/A

Quarterly Report - FORM 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q / A x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registra

May 15, 2012 10-Q

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant a

May 4, 2012 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 2, 2012 MEDICAL CARE TECHNOLOGIES INC.

May 4, 2012 EX-10.40

RESERVE EQUITY FINANCING AGREEMENT

EXHIBIT 10.40 RESERVE EQUITY FINANCING AGREEMENT THIS AGREEMENT dated as of the 27th day of April 2012 (the “Agreement”) between AGS Capital Group, LLC (the “Investor”), and Medical Care Technologies, Inc. (the “Company”). WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, the Company shall issue and sell to the Investor, from time to time as provided

May 4, 2012 EX-10.41

REGISTRATION RIGHTS AGREEMENT

EXHIBIT 10.42 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT dated as of the 27 day of April 2012 (the “Agreement”) between AGS Capital Group, LLC (the “Investor”), and Medical Care Technologies, Inc. (the “Company”). WHEREAS: A. In connection with the Reserve Equity Financing Agreement by and between the parties hereto of even date herewith (the “ Reserve Equity Financing Agreem

April 27, 2012 EX-10.39

MEDICAL CARE TECHNOLOGIES INC.

EXHIBIT 10.39 MEDICAL CARE TECHNOLOGIES INC. NING WU CEO AGREEMENT This Agreement is entered into as of April 23, 2012 by and between Medical Care Technologies Inc. (the “Company”) and Ning Wu (“CEO”). 1. Duties and Scope. (a) Positions and Duties. As of April 23, 2012 (the “Effective Date”), CEO will serve as President and Chief Executive Officer, reporting to the Company’s Board of Directors (th

April 27, 2012 EX-10.37

MEDICAL CARE TECHNOLOGIES INC. EXECUTIVE OFFICER EMPLOYMENT AGREEMENT

EXHIBIT 10.37 MEDICAL CARE TECHNOLOGIES INC. EXECUTIVE OFFICER EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is made between MEDICAL CARE TECHNOLOGIES INC. , a Nevada corporation (the “Company”) located at Room 815, No. 2 Building, Beixiaojie, Dongzhimen Nei, Beijing 10009, and Luis Kuo, (the “Executive”) with address at Richmond Hill, Ontario, Canada, (collectively so

April 27, 2012 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 23, 2012 MEDICAL CARE TECHNOLOGIES INC.

April 27, 2012 EX-10.38

SECOND AMENDMENT TO EXECUTIVE OFFICER EMPLOYMENT AGREEMENT

EXHIBIT 10.38 SECOND AMENDMENT TO EXECUTIVE OFFICER EMPLOYMENT AGREEMENT This Second Amendment to Executive Officer Employment Agreement (this “2nd Amendment”) is made and entered into effective as of April 23, 2012 (“Effective Date”) by and between Medical Care Technologies Inc., a Nevada corporation (the “Company”) and the Company’s Chief Operations Officer, Luis KUO (the “COO” or “KUO”). RECITA

April 16, 2012 10-K

Annual Report - ANNUAL REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES

April 16, 2012 EX-99.2

Medical Care

Exhibit 99.2 Medical Care Technologies Inc. CEO Letter to Shareholders Dear Valued Shareholder, I write to you at an important and extraordinary time for Medical Care Technologies Inc. We have made significant progress in implementing our business strategy and navigating our way through China’s health care sector in 2011. Here are just some of our highlights of 2011: · Appointed highly experienced

March 30, 2012 NT 10-K

- FORM 10-K EXTENSION

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 Commission File Number 000-53665 CUSIP Number: 584507107 NOTIFICATION OF LATE FILING (Check One): x Form 10-K o Form N-SAR o Form 20-F o Form N-CSR o Form 11-K o Form 10-Q o Form 10-D For Period Ended: December 31, 2011 o Transition Report on Form 10-K o Transition Report on Form 10-Q o Transition Report on Form 20-F o Transition Report on Form N-SAR o Transition Report on Form 11-K For the Transition Period Ended: Read instruction (on back page) before preparing form.

March 30, 2012 EX-3.3

Certificate of Amendment (PURSUANT TO NRS 78.385 AND 78.390) USE BLACK INK ONLY - DO NOT HIGHLIGHTABOVE SPACE IS FOR OFFICE USE ONLY Certificate of Amendment to Articles of Incorporation For Nevada Profit Corporations (Pursuant to NRS 78.385 and 78.3

Exhibit 3.3 ROSS MILLER Secretary of State 204 North Carson Street, Suite 1 Carson City, Nevada 89701-4520 (775) 684-5708 Website: www.nvsos.gov *090201* Certificate of Amendment (PURSUANT TO NRS 78.385 AND 78.390) USE BLACK INK ONLY - DO NOT HIGHLIGHTABOVE SPACE IS FOR OFFICE USE ONLY Certificate of Amendment to Articles of Incorporation For Nevada Profit Corporations (Pursuant to NRS 78.385 and

March 30, 2012 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report(Date of earliest event reported) March 29, 2012 Medical Care Technologies, Inc.

February 6, 2012 DEF 14A

- SCHEDULE 14A DEFINITIVE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of

January 24, 2012 PRE 14A

- SCHEDULE 14A PRELIMINARY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement o Confidential, for Use of

December 15, 2011 EX-4.13

MEDICAL CARE TECHNOLOGIES INC. Amended and Restated 15% Convertible Debenture Due December 9, 2013

Exhibit4.13 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION S

December 15, 2011 EX-10.35

STOCK ESCROW AGREEMENT

Exhibit 10.35 STOCK ESCROW AGREEMENT This Stock Escrow Agreement (this "Agreement") is made and entered into as of November , 2011 by and among between Long Side Ventures LLC, a Florida limited liability company ("Investor") Medical Care Technologies., Inc. (the “Company”), and Jonathan D. Leinwand, P.A. ("Escrow Agent"). Capitalized terms used herein but not otherwise defined shall have the meani

December 15, 2011 EX-10.34

DEBT PURCHASE AGREEMENT

Exhibit 10.34 DEBT PURCHASE AGREEMENT THIS AGREEMENTis made as of the 8 day of December, 2011 AMONG: LONG SIDE VENTURES LLC., a Florida limited liability company having an office for business located at 1800 S. Ocean Dr., PH2 , Hallandale Beach, Florida 33009(?Purchaser?) AND: CELINE WANG, an individual with an address 8 Gough Rd, The Peak, Hong Kong, (?Seller?) WHEREAS: A. Seller holds a certain

December 15, 2011 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 9, 2011 MEDICAL CARE TECHNOLOGIES INC.

December 15, 2011 EX-10.36

IRREVOCABLE TRANSFER AGENT INSTRUCTIONS

Exhibit 10.36 IRREVOCABLE TRANSFER AGENT INSTRUCTIONS December 15, 2011 Empire Stock Transfer Inc. 1859 Whitney Mesa Dr. Henderson, NV, 89014 RE: Medical Care Technologies Inc. Ladies and Gentlemen: Reference is made to that certain Convertible Debenture (the "Convertible Debenture"), dated the date hereof, by and between Medical Care Technologies, Inc., a corporation organized under the laws of N

November 17, 2011 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registra

November 14, 2011 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53665
 CUSIP NUMBER 584507107 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: September 30, 2011 o Tra

October 28, 2011 424B3

FILED PURSUANT TO RULE 424(B)(3) REGISTRATION NO. 333-177245

FILED PURSUANT TO RULE 424(B)(3) REGISTRATION NO. 333-177245 MEDICAL CARE TECHNOLOGIES INC. Shares of Common Stock We are offering up to 60,000,000 shares at a price per share of $0.01 on a best efforts basis. We are making this offering without the involvement of underwriters or broker-dealers. The shares of our common stock to be sold by us will be sold on our behalf by our executive officers an

October 24, 2011 S-1/A

As filed with the Securities and Exchange Commission on October 24, 2011 Registration No. 333-177245 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT THE SECURITIES ACT OF 1933 MEDICAL CARE

As filed with the Securities and Exchange Commission on October 24, 2011 Registration No.

October 11, 2011 EX-10.30

MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT

Exhibit 10.30 MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT This Stock Option Agreement (this ?Option?) is granted to the Optionee named above by Medical Care Technologies Inc. (the ?Corporation?) pursuant to the Medical Care Technologies Inc. 2010 Stock Option Plan (the ?Plan?) as of this 30th day of December, 2010, the date this Option was granted pursuant to the Plan. This Option provide

October 11, 2011 EX-10.1

LETTER OF INTENT

Exhibit 10.1 LETTER OF INTENT Parties: AM Oil Resources & Technology Inc., a Nevada corporation ("AM Oil"), and Great Union Corporation, a Hong Kong corporation ("Great Union"), wish to enter into this letter of intent (the "LOI") which will provide for the basic structure of a share exchange and reverse merger between the parties (the "Share Exchange"). It is the intention of the parties to enter

October 11, 2011 S-1

As filed with the Securities and Exchange Commission on October 11, 2011 Registration No. 333-_______ SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT THE SECURITIES ACT OF 1933 MEDICAL CARE TECHNOLOGIES INC.

As filed with the Securities and Exchange Commission on October 11, 2011 Registration No.

October 11, 2011 EX-10.2

ASSET ACQUISITION AGREEMENT

Exhibit 10.2 ASSET ACQUISITION AGREEMENT THIS AGREEMENT is made effective as of the 9th day of January, 2010 AMONGST: MEDICAL CARE TECHNOLOGIES INC., a Nevada corporation, having an office at 22 Notting Hill Gate, Suite 127, London, UK, X0 W11 3JE (the ?Purchaser?) AND: GREAT UNION CORPORATION a Hong Kong corporation, having an office at Room 25, Block A, 19th Floor, Wah Lok Industrial Court, 31-4

October 11, 2011 EX-21.1

SUBSIDIARIES

EXHIBIT 21.1 SUBSIDIARIES ReachOut Holdings Limited (Hong Kong) ? 65% ownership

October 11, 2011 EX-10.28

MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT

Exhibit 10.28 MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT This Stock Option Agreement (this ?Option?) is granted to the Optionee named above by Medical Care Technologies Inc. (the ?Corporation?) pursuant to the Medical Care Technologies Inc. 2010 Stock Option Plan (the ?Plan?) as of this 30th day of December, 2010, the date this Option was granted pursuant to the Plan. This Option provide

October 11, 2011 EX-10.32

MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT

Exhibit 10.32 MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT This Stock Option Agreement (this ?Option?) is granted to the Optionee named above by Medical Care Technologies Inc. (the ?Corporation?) pursuant to the Medical Care Technologies Inc. 2010 Stock Option Plan (the ?Plan?) as of this 30th day of December, 2010, the date this Option was granted pursuant to the Plan. This Option provide

October 11, 2011 EX-10.33

MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT

Exhibit 10.33 MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT This Stock Option Agreement (this ?Option?) is granted to the Optionee named above by Medical Care Technologies Inc. (the ?Corporation?) pursuant to the Medical Care Technologies Inc. 2010 Stock Option Plan (the ?Plan?) as of this 1st day of February, 2011, the date this Option was granted pursuant to the Plan. This Option provides

October 11, 2011 EX-10.29

MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT

Exhibit 10.29 MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT This Stock Option Agreement (this ?Option?) is granted to the Optionee named above by Medical Care Technologies Inc. (the ?Corporation?) pursuant to the Medical Care Technologies Inc. 2010 Stock Option Plan (the ?Plan?) as of this 30th day of December, 2010, the date this Option was granted pursuant to the Plan. This Option provide

October 11, 2011 EX-10.31

MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT

Exhibit 10.31 MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT This Stock Option Agreement (this ?Option?) is granted to the Optionee named above by Medical Care Technologies Inc. (the ?Corporation?) pursuant to the Medical Care Technologies Inc. 2010 Stock Option Plan (the ?Plan?) as of this 30th day of December, 2010, the date this Option was granted pursuant to the Plan. This Option provide

September 28, 2011 SC 13D

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 MEDICAL CARE TECHNOLOGIES, INC. (Name of Issuer) Shares of Common Stock, $0.00001 Par Value (Title of Class of Securities)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment1) MEDICAL CARE TECHNOLOGIES, INC. (Name of Issuer) Shares of Common Stock, $0.00001 Par Value (Title of Class of Securities) 584507107 (CUSIP Number) Ning C. Wu, CEO Room 815, No. 2 Building Beixiaojie Dongzhimen Nei, Beijing 10009 People?s Republic of China Tel

September 28, 2011 EX-3

STOCK PURCHASE AGREEMENT

Exhibit 3 STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT (this “Agreement”) dated as of September 19, 2011 between Ning Wu (the “Seller”) and (the “Purchaser”).

September 28, 2011 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 19, 2011 MEDICAL CARE TEC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 19, 2011 MEDICAL CARE TECHNOLOGIES INC.

September 15, 2011 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 9, 2011 MEDICAL CARE TECH

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 9, 2011 MEDICAL CARE TECHNOLOGIES INC.

September 15, 2011 EX-4.93

Principal Amount: $45,000.00 Issue Date: September 9, 2011

Exhibit 4.93 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR

September 15, 2011 EX-10.23

SECURITIES PURCHASE AGREEMENT

Exhibit 10.23 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 9, 2011, by and between MEDICAL CARE TECHNOLOGIES INC., a Nevada corporation, with headquarters located at Room 815, No. 2 Building Beixiaojie, DongzhimenNei, Beijing, People's Republic of China 10009 (the “Company”), and ASHER ENTERPRISES, INC., a Delaware corporation, with its

August 22, 2011 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant as

August 15, 2011 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: November 30, 2012 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53665
 CUSIP NUMBER 584507107 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: June 3

August 10, 2011 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 4, 2011 MEDICAL CARE TECHNOLOGIES INC.

August 10, 2011 EX-10.22

FIRST AMENDMENT TO EXECUTIVE OFFICER EMPLOYMENT AGREEMENT

Exhibit 10.22 FIRST AMENDMENT TO EXECUTIVE OFFICER EMPLOYMENT AGREEMENT This First Amendment to Executive Officer Employment Agreement (this ?1st Amendment?) is made and entered into effective as of August 1, 2011 (?Effective Date?) by and between Medical Care Technologies Inc., a Nevada corporation (the ?Company?) and the Company?s Chief Operations Officer, Luis KUO (the ?COO? or ?KUO?). RECITALS

July 28, 2011 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 20, 2011 MEDICAL CARE TECHNOLOGIES INC.

July 28, 2011 EX-10.21

SECURITIES PURCHASE AGREEMENT

Exhibit 10.21 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 20, 2011, by and between MEDICAL CARE TECHNOLOGIES INC., a Nevada corporation, with headquarters located at Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei, Beijing, People's Republic of China 10009 (the “Company”), and ASHER ENTERPRISES, INC., a Delaware corporation, with its add

July 28, 2011 EX-4.92

1

EXHIBIT 4.92 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR

June 28, 2011 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2011 OR o TRANSITION REPORT PURSUANT T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant

June 27, 2011 CORRESP

-

CORRESP 1 filename1.htm MEDICAL CARE TECHNOLOGIES, INC. Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei Beijing, China 10009 Via EDGAR June 27, 2011 Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.W. Washington, D.C. 20549-0406 Attention: Ernest Greene Re: Medical Care Technologies, Inc. Form 10-K/A for the year ended December 31, 2010 Form 10-Q/A for the perio

June 27, 2011 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 2) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2010 o TRANSITION REPORT UND

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 2) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2010 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-53665 MEDICAL CARE TECHNOLO

June 27, 2011 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K/A (Amendment No. 2)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K/A (Amendment No. 2) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-53665 MEDIC

June 27, 2011 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 2) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2010 o TRANSITION REPORT UNDER SE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 2) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2010 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES,

June 9, 2011 EX-4.91

Principal Amount: $32,500.00 Purchase Price: $32,500.00 Issue Date: June 1, 2011 CONVERTIBLE PROMISSORY NOTE

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

June 9, 2011 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 21, 2011 MEDICAL CARE TECHNOL

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 21, 2011 MEDICAL CARE TECHNOLOGIES INC.

June 9, 2011 EX-10.20

SECURITIES PURCHASE AGREEMENT

Exhibit 10.20 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 1, 2011, by and between MEDICAL CARE TECHNOLOGIES INC., a Nevada corporation, with headquarters located at Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei, Beijing, People's Republic of China 10009 (the “Company”), and ASHER ENTERPRISES, INC., a Delaware corporation, with its addr

June 2, 2011 S-8

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-8 REGISTRATION STATEMENT THE SECURITIES ACT OF 1933 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDICAL CARE TECHNOLOGIES INC.

June 2, 2011 EX-99.1

AGREEMENT ARTICLE I RELATIONSHIP OF THE PARTIES

Exhibit 99.1 THIS MANAGEMENT SERVICES AGREEMENT (the "Agreement") is entered into as of April 1, 2011 (the "Effective Date") by and between Medical Care Technologies Inc., a Nevada corporation ("MDCE"), and LOW Sze Man, an individual experienced in business and administrative management in the People’s Republic of China (the "Management Person"). RECITALS - A. MDCE, through its Hong Kong and Chine

June 2, 2011 EX-99.3

1

Exhibit 99.3 AGREEMENT FOR MANAGEMENT ADVISORY SERVICES THIS MANAGEMENT ADVISORY SERVICES AGREEMENT (this "Agreement") is made as of May 10, 2011, between Medical Care Technologies Inc., a Nevada corporation (the "Company"), and YIU Chung Han, an individual and business manager ("Advisor"). WHEREAS, the Company and Advisor are entering into this Agreement pursuant to that certain Joint Venture Mas

June 2, 2011 EX-99.4

AGREEMENT FOR CONSULTING SERVICES

Exhibit 99.4 AGREEMENT FOR CONSULTING SERVICES AGREEMENT made and entered into as of this 16th of May 2011 (the "Agreement"), by and between Medical Care Technologies Inc. (the ?Company?) located at Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei, Beijing 10009 and Nicola Suppa (?the Consultant?), located at 1035 Country Club Dive, Suite 206, Margate FL 33063. RECITALS WHEREAS, the Consultant

June 2, 2011 EX-99.2

1

Exhibit 99.2 ADMINISTRATIVE SERVICES (the "Agreement") dated as of April 1, 2011 between Medical Care Technologies Inc., a Nevada corporation ("MDCE") and LIEW Kit Ha ("LIEW"), an individual. For good and valuable consideration, the receipt and legal sufficiency of which are hereby expressly acknowledged, the parties hereto agree as follows: 1. Engagement. Upon the terms and subject to the conditi

June 1, 2011 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of regist

June 1, 2011 EX-10.6

ACCREDITED MEMBERS, INC. ANNUAL PROFILE AGREEMENT

Exhibit 10.6 ACCREDITED MEMBERS, INC. ANNUAL PROFILE AGREEMENT This Annual Profile Agreement is entered into between Medical Care Technologies, Inc. (“Customer”) located at #888-33 Hazelton Ave., Toronto, ONM5R 2E3 and Accredited Members, Inc. (“AMI”). This Agreement, along with the Accredited Members, Inc. Terms and Conditions (the “Terms and Conditions”) governs the terms and conditions upon whi

June 1, 2011 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K/A x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-53665 MEDICAL CARE TECHNOLOGI

June 1, 2011 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2010 [ ] TRANSITION REPORT PURSUANT T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2010 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registr

May 31, 2011 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 19, 2011 MEDICAL CARE TECHNOLOG

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 19, 2011 MEDICAL CARE TECHNOLOGIES INC.

May 23, 2011 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2011 OR o TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant a

May 17, 2011 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53665 CUSIP NUMBER 584507107 NOTIFICATION OF LATE FILING (Check one): o Form 10-K oForm 20-F o Form 11-K x Form 10-Q o Form 10-D oForm N-SAR o Form N-CSR For Period Ended March 31, 2011 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transitio

May 6, 2011 EX-4.9

CONVERTIBLE PROMISSORY NOTE

Exhibit 4.9 CONVERTIBLE PROMISSORY NOTE THIS NOTE AND ANY SHARES OF STOCK ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THIS NOTE AND ANY SHARES OF STOCK ISSUABLE UPON THE CONVERSION HEREOF MAY NOT BE SOLD, OFFERED FOR SALE, OR OTHERWISE TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMEN

May 6, 2011 EX-10.19

Dated the 28th day of April, 2011 Medical Care Technologies Inc. Ocean Wise International Industrial Limited JOINT-VENTURE MASTER AGREEMENT Table of Contents

Exhibit 10.19 Dated the 28th day of April, 2011 Medical Care Technologies Inc. and Ocean Wise International Industrial Limited JOINT-VENTURE MASTER AGREEMENT Table of Contents Chapter 1. General 3 2. Parties 3 3. Establishment of Joint Venture Company 3 4. Purposes, Scope and Scale of Business 4 5. Total Amount of Investment and Registered Capital 4 6. Responsibilities of the Parties 6 7. Doing Bu

May 6, 2011 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 28, 2011 MEDICAL CARE TECHNOL

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 28, 2011 MEDICAL CARE TECHNOLOGIES INC.

April 22, 2011 EX-10.14

SECURITIES PURCHASE AGREEMENT

Exhibit 10.14 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 12, 2011, by and between MEDICAL CARE TECHNOLOGIES INC., a Nevada corporation, with headquarters located at Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei, Beijing, People's Republic of China 10009 (the “Company”), and ASHER ENTERPRISES, INC., a Delaware corporation, with its ad

April 22, 2011 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 21, 2011 MEDICAL CARE TECHNOLOGIES INC.

April 22, 2011 EX-4.8

Principal Amount: $32,500.00 Issue Date: April 12, 2011 Purchase Price: $32,500.00

Exhibit 4.8 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T

April 1, 2011 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: November 30, 2012 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53665
 CUSIP NUMBER (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: December 31, 201

April 1, 2011 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES

March 24, 2011 EX-10.13

SECURITIES PURCHASE AGREEMENT

Exhibit 10.13 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 11, 2011, by and between MEDICAL CARE TECHNOLOGIES INC., a Nevada corporation, with headquarters located at Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei, Beijing, People's Republic of China 10009 (the “Company”), and ASHER ENTERPRISES, INC., a Delaware corporation, with its ad

March 24, 2011 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 21, 2011 MEDICAL CARE TECHNOLOGIES INC.

March 24, 2011 EX-4.7

Principal Amount: $32,500.00 Issue Date: March 11, 2011 Purchase Price: $32,500.00 CONVERTIBLE PROMISSORY NOTE

Exhibit 4.7 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T

February 16, 2011 EX-10.12

SECURITIES PURCHASE AGREEMENT

EX-10.12 3 f8k020111ex10xiimedcaretech.htm SECURITIES PURCHASE AGREEMENT Exhibit 10.12 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 1, 2011, by and between MEDICAL CARE TECHNOLOGIES INC., a Nevada corporation, with headquarters located at Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei, Beijing, People's Republic of China 10009 (the “

February 16, 2011 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 1, 2011 MEDICAL CARE TECHNOLOGIES INC.

February 16, 2011 EX-4.6

Principal Amount: $50,000.00 Issue Date: February 1, 2011 Purchase Price: $50,000.00

Exhibit 4.6 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T

January 5, 2011 EX-10.11

English Translation Contractor Agreement

Exhibit 10.11 Consulting and Custom Software Development & Upgrade English Translation Contractor Agreement This Agreement is effective as of the date of the party last signing below by and between MEDICAL CARE TECHNOLOGIES INC. (the ?Company?), with offices at Room 815, No. 2 Building, Beixiaojie, Dongzhimen Nei, Beijing, China 10009, and L. Eddison Parke, Information Technology Technicians & Con

January 5, 2011 EX-10.7

ADMINISTRATIVE SERVICES AGREEMENT

Exhibit 10.7 ADMINISTRATIVE SERVICES AGREEMENT ADMINISTRATIVE SERVICES (the "Agreement") dated as of August 31, 2010 between KAREN A. VINCENT, an individual ("VINCENT") and MEDICAL CARE TECHNOLOGIES, INC., a Nevada corporation ("Medical Care"). For good and valuable consideration, the receipt and legal sufficiency of which are hereby expressly acknowledged, the parties hereto agree as follows: 1.

January 5, 2011 EX-4.3

MEDICAL CARE TECHOLOGIES INC. 2010 STOCK OPTION PLAN

Exhibit 4.3 MEDICAL CARE TECHOLOGIES INC. 2010 STOCK OPTION PLAN Section 1. Establishment and Purpose. The name of the plan is the Medical Care Technologies Inc. 2010 Stock Option Plan (the "Plan"). The purpose of the Plan is to provide key employees, officers, directors, consultants and agents of Medical Care Technologies Inc. and its subsidiaries (the "Company") added incentive for high levels o

January 5, 2011 EX-10.10

MEDICAL CARE TECHNOLOGIES, INC. BUSINESS ADVISORY & CONSULTING AGREEMENT

Exhibit 10.10 MEDICAL CARE TECHNOLOGIES, INC. BUSINESS ADVISORY & CONSULTING AGREEMENT AGREEMENT made as of the 1st day of October, 2010 ( the “Effective Date”), by and between Shu Zhen Bei (“Consultant”), and Medical Care Technologies, Inc. (hereafter referred to as “MDCE”) having a place of business at Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei, Beijing 10009. WHEREAS, The Company has e

January 5, 2011 EX-10.9

ADMINISTRATIVE SERVICES AGREEMENT

Exhibit 10.9 ADMINISTRATIVE SERVICES AGREEMENT ADMINISTRATIVE SERVICES (the "Agreement") dated as of November 15, 2010 between GRETTA MOY, an individual ("MOY") and Medical Care Technologies Inc., a Nevada corporation ("Medical Care"). For good and valuable consideration, the receipt and legal sufficiency of which are hereby expressly acknowledged, the parties hereto agree as follows: 1. Engagemen

January 5, 2011 EX-10.8

ADMINISTRATIVE SERVICES AGREEMENT

Exhibit 10.8 ADMINISTRATIVE SERVICES AGREEMENT ADMINISTRATIVE SERVICES (the "Agreement") dated as of September 2, 2010 between ANNA TANG, an individual ("TANG") and MEDICAL CARE TECHNOLOGIES, INC., a Nevada corporation ("Medical Care"). For good and valuable consideration, the receipt and legal sufficiency of which are hereby expressly acknowledged, the parties hereto agree as follows: 1. Engageme

January 5, 2011 EX-4.4

MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT

Exhibit 4.4 MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT This Stock Option Agreement (this ?Option?) is granted to the Optionee named above by Medical Care Technologies Inc. (the ?Corporation?) pursuant to the Medical Care Technologies Inc. 2010 Stock Option Plan (the ?Plan?) as of this day of , 201, the date this Option was granted pursuant to the Plan. This Option provides you an option

January 5, 2011 S-8

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-8 REGISTRATION STATEMENT THE SECURITIES ACT OF 1933 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDICAL CARE TECHNOLOGIES INC.

December 28, 2010 DEF 14C

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C (Rule 14C-101) SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) Of the Securities Exchange Act of 1934 (Amendment No. ___)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C (Rule 14C-101) SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) Of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: o Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d) (1)) x Definitive Information Statement MEDI

December 7, 2010 PRE 14C

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C (Rule 14C-101) SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) Of the Securities Exchange Act of 1934 (Amendment No. ___)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C (Rule 14C-101) SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) Of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: x Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d) (1)) o Definitive Information Statement MEDI

November 19, 2010 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registra

November 19, 2010 EX-10.6

ACCREDITED MEMBERS, INC. ANNUAL PROFILE AGREEMENT

Exhibit 10.6 ACCREDITED MEMBERS, INC. ANNUAL PROFILE AGREEMENT This Annual Profile Agreement is entered into between Medical Care Technologies, Inc. (?Customer?) located at #888-33 Hazelton Ave., Toronto, ONM5R 2E3 and Accredited Members, Inc. (?AMI?). This Agreement, along with the Accredited Members, Inc. Terms and Conditions (the ?Terms and Conditions?) governs the terms and conditions upon whi

November 16, 2010 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: November 30, 2012 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53665 CUSIP NUMBER 584507107 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: Septemb

October 12, 2010 EX-7.1

CEO AMENDMENT AGREEMENT

Exhibit 7.1 CEO AMENDMENT AGREEMENT THIS AMENDMENT AGREEMENT, dated as of September 13, 2010 (hereafter, the ?Amendment Agreement?), is entered into between Medical Care Technologies Inc., a Nevada corporation, (hereafter, the ?Company?), and Ning C. Wu, an individual (hereafter, the ?Management Consultant?). WHEREAS, the Company and the Management Consultant had entered into a consultancy agreeme

October 12, 2010 EX-7.2

Lock-Up Agreement

Exhibit 7.2 Lock-Up Agreement THIS LOCK-UP AGREEMENT (this “Agreement”) is entered into as of September 13, 2010 between Ning Wu (“Wu”) and MEDICAL CARE TECHNOLOGIES INC., a Nevada corporation (the “Company”). WHEREAS, Wu holds 38,000,000 restricted common stock of the Company, par value $0.00001 (the “Company Common Stock”); WHEREAS, the Company believes it is in the best interests of its stockho

October 12, 2010 SC 13D

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 MEDICAL CARE TECHNOLOGIES, INC. (Name of Issuer) Shares of Common Stock, $0.00001 Par Value (Title of Class of Securities)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment) MEDICAL CARE TECHNOLOGIES, INC. (Name of Issuer) Shares of Common Stock, $0.00001 Par Value (Title of Class of Securities) 584507107 (CUSIP Number) Ning C. Wu, CEO Room 815, No. 2 Building Beixiaojie Dongzhimen Nei, Beijing 10009 People?s Republic of China Tele

September 20, 2010 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 13, 2010 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter) Nevada 000-53665 N/A (State or other jurisdiction of incorporation) (Commission

September 20, 2010 EX-10.5

MEDICAL CARE TECHNOLOGIES INC. NING WU CONSULTANCY AGREEMENT

Exhibit 10.5 MEDICAL CARE TECHNOLOGIES INC. NING WU CONSULTANCY AGREEMENT This Agreement is entered into as of November 25, 2009 by and between Medical Care Technologies Inc. (the “Company”) and Ning Wu (“Consultant”). 1. Duties and Scope of Consultancy. (a) Positions and Duties. As of November 25, 2009 (the “Effective Date”), Consultant will serve as President and Chief Executive Officer, reporti

September 20, 2010 EX-99.1

Certificate of Amendment (PURSUANT TO NRS 78.385 AND 78.390)

Exhibit 99.1 ROSS MILLER Secretary of State 204 North Carson Street, Ste 1 Carson City, Nevada 89701-4069 (775) 684-5708 Website: www.nvsos.gov Certificate of Amendment (PURSUANT TO NRS 78.385 AND 78.390) USE BLACK INK ONLY ? DO NOT HIGHLIGHT ABOVE SPACE FOR OFFICE USE ONLY Certificate of Amendment to Articles of Incorporation For Nevada Profit Corporation Pursuant to NRS 78.385 and 78.390 - (Afte

September 20, 2010 EX-10.3

CEO AMENDMENT AGREEMENT

Exhibit 10.3 CEO AMENDMENT AGREEMENT THIS AMENDMENT AGREEMENT, dated as of September 13, 2010 (hereafter, the ?Amendment Agreement?), is entered into between Medical Care Technologies Inc., a Nevada corporation, (hereafter, the ?Company?), and Ning C. Wu, an individual (hereafter, the ?Management Consultant?). WHEREAS, the Company and the Management Consultant had entered into a consultancy agreem

September 20, 2010 EX-10.4

Lock-Up Agreement

Exhibit 10.4 Lock-Up Agreement THIS LOCK-UP AGREEMENT (this “Agreement”) is entered into as of September 13, 2010 between Ning Wu (“Wu”) and MEDICAL CARE TECHNOLOGIES INC., a Nevada corporation (the “Company”). WHEREAS, Wu holds 38,000,000 restricted common stock of the Company, par value $0.00001 (the “Company Common Stock”); WHEREAS, the Company believes it is in the best interests of its stockh

September 7, 2010 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 1, 2010 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter) Nevada 000-53665 N/A (State or other jurisdiction of incorporation) (Commission

August 16, 2010 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2010 [ ] TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2010 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registran

May 24, 2010 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2010 [ ] TRANSITION REPORT PURSUANT TO

Medical Care Technologies Inc. - Form 10-Q - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2010 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file

May 18, 2010 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one):

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2012 Estimated average burden hours per response .... 2.50 SEC FILE NUMBER 000-53665 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ x ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: March 31, 2010 [ ]

May 17, 2010 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 10, 2010 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter) Nevada 000-53665 N/A (State or other jurisdiction of (Commission File Number) (IRS Em

April 12, 2010 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2009 [ ] TRANSITION REPORT PURSUANT TO

Medical Care Technologies Inc.: Form 10-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2009 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition

April 9, 2010 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q /A Amendment #1 [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2009 [ ] TRANSITION RE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q /A Amendment #1 [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2009 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 AM OIL RESOURCES & TECHNOLOGY INC. (Ex

April 9, 2010 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q /A Amendment #1 [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2009 [ ] TRANSITION REP

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q /A Amendment #1 [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2009 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 AM OIL RESOURCES & TECHNOLOGY INC. (Exa

April 1, 2010 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one):

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2012 Estimated average burden hours per response .... 2.50 SEC FILE NUMBER 000-53665 [ x ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: December 31, 2009

February 11, 2010 DEFR14A

SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only [as permitted by Rule 14a-6(e)(2)] [X] Definitive Proxy Statement [ ] Definitive Additional Materials [ ] Soliciting Material Pursuant to Section 240.

January 22, 2010 DEF 14A

SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only [as permitted by Rule 14a-6(e)(2)] [X] Definitive Proxy Statement [ ] Definitive Additional Materials [ ] Soliciting Material Pursuant to Section 240.

January 20, 2010 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 20, 2010 (January 20, 2010) MEDICAL CARE TEHCNOLOGIES INC. (Exact name of registrant as specified in its charter) NEVADA 000-53665 (State or other jurisdiction of incorporation

January 14, 2010 EX-99.1

MEDICAL CARE TECHNOLOGIES INC. APPOINTS KEY MEMBER TO ITS ADVISORY BOARD

Exhibit 99.1 FOR IMMEDIATE RELEASE MEDICAL CARE TECHNOLOGIES INC. APPOINTS KEY MEMBER TO ITS ADVISORY BOARD LONDON, ENGLAND – January 11, 2010 – Medical Care Technologies Inc. (OTCBB: MDCE) today announced that Minh Nguyen was elected as an Advisory Board Member to the Company. Ms. Nguyen brings extensive knowledge of business, as well as experience in several industries, including international b

January 14, 2010 EX-99.5

MEDICAL CARE TECHNOLOGIES INC. COMMENCES TRIALS FOR CONTINUOUS GLUCOSE MONITORING AS ADD-ON

Exhibit 99.5 FOR IMMEDIATE RELEASE MEDICAL CARE TECHNOLOGIES INC. COMMENCES TRIALS FOR CONTINUOUS GLUCOSE MONITORING AS ADD-ON LONDON, ENGLAND – January 13, 2010 – Medical Care Technologies Inc. (OTCBB: MDCE) today announced that it has commenced trials to include Continuous Glucose Monitoring (CGM) to its current Tele-Health™ Suite. Management believes that by adding this function to its Tele-Hea

January 14, 2010 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 14, 2010 (January 9, 2010)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 14, 2010 (January 9, 2010) MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter) NEVADA 000-53665 (State or other jurisdiction of incorporation)

January 14, 2010 EX-99.4

Medical Care Technologies Inc. Completes International Secure Practice Management Suite for Testing in China

Exhibit 99.4 Medical Care Technologies Inc. Completes International Secure Practice Management Suite for Testing in China LONDON, ENGLAND ? January 12, 2010 ? Medical Care Technologies Inc. (OTCBB: MDCE) announces the completion of a secure practice management system for medical clinics in China. The deployment of our MedSuite technology will allow the first test site in Hebei Province to institut

January 14, 2010 EX-99.3

MEDICAL CARE TECHNOLOGIES INC. ANNOUNCES APPOINTMENT OF NEW CEO

Exhibit 99.3 FOR IMMEDIATE RELEASE MEDICAL CARE TECHNOLOGIES INC. ANNOUNCES APPOINTMENT OF NEW CEO LONDON, ENGLAND – January 12, 2010 – Medical Care Technologies Inc. (OTCBB: MDCE) today announced that Ning C. Wu has joined MDCE as its new President, Chief Executive Officer, and Chief Financial Officer effective immediately. Ms. Wu is a seasoned entrepreneur with over 25 years experience in both t

January 14, 2010 EX-99.6

Medical Care Technologies Inc. Secures Financing

Exhibit 99.6 FOR IMMEDIATE RELEASE Medical Care Technologies Inc. Secures Financing LONDON, ENGLAND ? January 13, 2010 ? Medical Care Technologies Inc. (OTCBB: MDCE) announces that it has completed a non-brokered private placement of 500,000 units at a price of US$0.20 per unit for total proceeds of US$100,000. Each unit purchased is of one share of common stock, and one Series A Warrant. Each Ser

January 14, 2010 EX-99.2

MEDICAL CARE TECHNOLOGIES INC. SIGNS ASSET ACQUISITION AGREEMENT

Exhibit 99.2 FOR IMMEDIATE RELEASE MEDICAL CARE TECHNOLOGIES INC. SIGNS ASSET ACQUISITION AGREEMENT LONDON, ENGLAND – January 11, 2010 – Medical Care Technologies Inc. (OTCBB: MDCE) today announced that it has reached a definitive agreement to acquire various technologies from Great Union Corporation, (“GUC”) a private Hong Kong corporation. The Boards of Directors of both companies have unanimous

January 11, 2010 EX-99.1

MEDICAL CARE TECHNOLOGIES INC. PROVIDES CORPORATE UPDATE

Exhibit 99.1 FOR IMMEDIATE RELEASE MEDICAL CARE TECHNOLOGIES INC. PROVIDES CORPORATE UPDATE LONDON, ENGLAND – January 8, 2010 – Medical Care Technologies Inc. (OTCBB: MDCE) would like to provide its shareholders with a corporate update. On October 6, 2009, MDCE entered into a non-binding Letter of Intent with Great Union Corporation, (“GUC”) a Hong Kong corporation, with the intent to acquire owne

January 11, 2010 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: January 8, 2010 Commission File Number: 000-53665 MEDICAL CARE TECH

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: January 8, 2010 Commission File Number: 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact Name of Registrant as Specified in Charter) NEVADA (state or other jurisdiction of incorporation or organization) 22 Notting Hill

November 23, 2009 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2009 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES, INC. (Formerly AM Oil R

November 20, 2009 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: November 20, 2009 Commission File Number: 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact Name of Registrant as Specified in Charter) NEVADA (state or other jurisdiction of incorporation or organization) 22 Notting Hi

November 17, 2009 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For the period ended September 30, 2009 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q For the

October 20, 2009 EX-2.1

EX-2.1

Exhibit 2.1

October 20, 2009 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: October 13, 2009 Commission File Number: 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact Name of Registrant as Specified in Charter) NEVADA (state or other jurisdiction of incorporation or organization) 22 Notting Hil

October 1, 2009 8-K

Current Report

8-K 1 amoil8k092809.htm AM OIL RESOURCES & TECHNOLOGY INC. FORM 8-K FOR SEPTEMBER 28, 2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 28, 2009 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.)

August 14, 2009 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2009 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 AM OIL RESOURCES & TECHNOLOGY INC. (Exact name of regis

July 22, 2009 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 20, 2009 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as specified in its charter) NEVADA 000-53665 (State or other jurisdi

July 16, 2009 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 7, 2009 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as specified in its charter) NEVADA 000-53665 (State or other jurisdic

July 9, 2009 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 7, 2009 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as specified in its charter) NEVADA 000-53665 (State or other jurisdic

June 30, 2009 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 29, 2009 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as specified in its charter) NEVADA 000-53665 (State or other jurisdi

June 17, 2009 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2009 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 AM OIL RESOURCES & TECHNOLOGY INC. (Exact name of regi

May 22, 2009 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 11, 2009 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as specified in its charter) NEVADA 000-53665 (State or other jurisdic

May 18, 2009 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For the period ended March 31, 2009 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q For the Tran

May 7, 2009 8-A12G

SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) or (g) OF THE SECURITIES EXCHANGE ACT OF 1934 AM OIL RESOURCES & TECHNOLOGY INC. (Exact name of registrant

AM Oil Resources & Technology Inc. Form 8-A SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) or (g) OF THE SECURITIES EXCHANGE ACT OF 1934 AM OIL RESOURCES & TECHNOLOGY INC. (Exact name of registrant as specified in its charter.) Nevada (State of incorporation of organization) 27240 Turnberry Lane, Suite

April 15, 2009 EX-14.1

AM OIL RESOURCES & TECHNOLOGY INC. CODE OF ETHICS TOPICS

Code of Ethics Exhibit 14.1 AM OIL RESOURCES & TECHNOLOGY INC. CODE OF ETHICS TOPICS 1. Statement of Policy 2. Implementation and Enforcement 3. Relations with Competitors and Other Third Parties 4. Insider Trading, Securities Compliance and Public Statements 5. Financial Reporting 6. Human Resources 7. Environmental, Health and Safety 8. Conflicts of Interest 9. International Trade 10. Government

April 15, 2009 EX-10.1

ASSET PURCHASE AGREEMENT

Exhibit 10.1 ASSET PURCHASE AGREEMENT This Asset Purchase Agreement (this ?Agreement?), dated November 25, 2008, is made between AM Oil Resources & Technology Inc., residing in the State of California (?Sellers?) and Aventerra Explorations, Inc., a Nevada corporation (the ? Buyer ?). RECITALS WHEREAS, the Buyer desires to acquire from the Sellers, the assets listed on ?Exhibit A? attached hereto (

April 15, 2009 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2008 Commission file number 333-151332 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as specified in its charter) Nevada (State or oth

April 15, 2009 EX-99.1

AM OIL RESOURCES & TECHNOLOGY INC. CHARTER - AUDIT COMMITTEE Committee Role

Exhibit 99.1 AM OIL RESOURCES & TECHNOLOGY INC. CHARTER - AUDIT COMMITTEE Committee Role The committee's role is to act on behalf of the board of directors and oversee all material aspects of the company's reporting, control, and audit functions, except those specifically related to the responsibilities of another standing committee of the board. The audit committee's role includes a particular fo

April 15, 2009 EX-10.2

AMENDMENT TO AGREEMENT

Exhibit 10.2 AMENDMENT TO AGREEMENT AMENDMENT TO AGREEMENT dated November 25, 2008, between AM Oil Resources & Technology, Inc. formerly Aventerra Explorations, Inc. hereinafter collectively referred to as ?Buyer? and AM Oil Resources & Technology Inc., a California corporation, hereinafter collectively referred to as "Seller?. WHEREAS, the parties desire to amended the agreement entered into betw

April 15, 2009 EX-99.2

AM OIL RESOURCES & TECHNOLOGY INC. DISCLOSURE COMMITTEE CHARTER

Exhibit 99.2 AM OIL RESOURCES & TECHNOLOGY INC. DISCLOSURE COMMITTEE CHARTER Disclosure Policy All financial disclosures made by the Corporation to its security holders or the investment community should (i) be accurate, complete and timely, (ii) fairly present, in all material respects, the Corporation's financial condition, results of operations and cash flows, and (iii) meet any other legal, re

April 1, 2009 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For the period ended December 31, 2008. [ ] Transition Report on Form 10-K. [ ] Transition Report on Form 20-F. [ ] Transition Report on Form 11-K. [ ] Transition Report on Form 10-Q. For

March 2, 2009 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 25, 2008 AM OIL RESOURCES

AM Oil Resources & Technology Inc. Form 8K for November 25, 2008 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 25, 2008 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant

February 2, 2009 EX-99.1

AM Oil Resources & Technology Outlines Goal for 2009

Exhibit 99.1 AM Oil Resources & Technology Outlines Goal for 2009 VALENCIA, CALIFORNIA, January 30, 2009 (BUSINESSWIRE) ? AM Oil Resources & Technology Inc., (OTCBB: AMOR.OB) announced today that it intends to build approximately 20 of its patented MT-06 Portable Steam Systems in 2009. As previously stated, each Portable Steam Systems used by the Company is capable of producing from $2-$6 million

February 2, 2009 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January

AM Oil Resources & Technology Inc. Form 8-K for 01-30-2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 30, 2009 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as spec

January 29, 2009 EX-99.1

AM Oil Resources & Technology to Seek Product Exposure Through Media Outlets

Exhibit 99.1 AM Oil Resources & Technology to Seek Product Exposure Through Media Outlets VALENCIA, CALIFORNIA, January 28, 2009 (BUSINESSWIRE) ? AM Oil Resources & Technology Inc., (OTCBB: AMOR) announced today that the Company has adopted a strategy of pursuing air time and space on print and media outlets to increase awareness of its patented products and technologies for maximizing crude oil r

January 29, 2009 EX-99.1

AM Oil Resources & Technology Acquires Build Biodiesel Technology to Create Energy Diversity

Exhibit 99.1 AM Oil Resources & Technology Acquires Build Biodiesel Technology to Create Energy Diversity VALENCIA, CALIFORNIA, January 26, 2009 (BUSINESSWIRE) ? AM Oil Resources & Technology Inc., (OTCBB: AMOR.OB) announced today that it has just completed design drawings to build a mobile bio-diesel device. The Company?s design is a mobile biodiesel production plant, capable of producing 2,000 t

January 29, 2009 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January

AM Oil Resources & Technology Inc. Form 8-K for January 28, 2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 28, 2009 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant a

January 29, 2009 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January

AM Oil Resources & Technology Inc. Form 8-K for January 26, 2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 26, 2009 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant a

January 26, 2009 EX-99

AM Oil Resources & Technology New Company Brochure Available on the Company’s Website

Exhibit 99.1 AM Oil Resources & Technology New Company Brochure Available on the Company?s Website VALENCIA, CALIFORNIA, January 23, 2009 (BUSINESSWIRE) ? AM Oil Resources & Technology Inc., (OTC:BB: AMOR.OB) announce today that it has created a new company brochure to provide the public and its current shareholders with additional detailed information related to the Company and the oil and gas ma

January 26, 2009 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 23, 2009 - (January 23, 2009) AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as specified in its charter) NEVADA 333-15133

December 24, 2008 EX-99.1

AM Oil Resources & Technology Inc. Announces New Direction for the Company and Appoints New Directors

Exhibit 99.1 AM Oil Resources & Technology Inc. Announces New Direction for the Company and Appoints New Directors VALENCIA, Calif.-(BUSINESS WIRE)- AM Oil Resources & Technology Inc., (OTCBB:AXPI) today announced that the Officers and Directors have begun to chart a new course for the Company. Since inception, the prior company was involved in the mining business with properties held for explorat

December 24, 2008 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December

AM Oil Resources & Technology Inc. Form 8-K for December 24, 2008 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 24, 2008 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant

December 22, 2008 EX-99.1

AM Oil Resources & Technology Inc. Philip Morgan 800-646-6570 [email protected] www.am-oil.com

Exhibit 99.1 AM Oil Resources & Technology Inc., Formerly Known as Aventerra Exploration, Inc., Announces the Acquisition of Patented Oil Recovery Technology VALENCIA, Calif.- December 22, 2008 - (BUSINESS WIRE)- AM Oil Resources & Technology Inc. (OTCBB: AXPI) announced that the Company has acquired two patents from AM Oil Resources & Technology Inc., a California corporation ("AM Oil"). The Comp

December 22, 2008 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 3, 2008 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as specified in its charter) NEVADA 333-151332 (State or other jur

December 22, 2008 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 22, 2008 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as specified in its charter) NEVADA 333-151332 (State or other ju

December 22, 2008 EX-3

Name of corporation:

AM Oil Resources & Technology Inc. Exhibit 3.3 Exhibit 3.3 ROSS MILLER Filed in the office of Document Number Secretary of State ROSS MILLER 20080787612-41 [SEAL] 204 North Carson Street, Ste 1 Ross Miller Filing Date and Time Carson City, Nevada 89701-4299 Secretary of State 12/03/2008 3:40 PM (775) 684 5708 State of Nevada Entity Number Website: nvsos.gov E0136282007-6 Certificate of Amendment (

December 1, 2008 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November

Aventerra Explorations, Inc. Form 8-K for November 25, 2008 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 25, 2008 AVENTERRA EXPLORATIONS, INC. (Formerly Ridgestone Resources, Inc.) (Exact name of registrant as specified

November 18, 2008 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A-1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A-1 [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2008 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 333-151332 AVENTERRA EXPLORATIONS, INC. (Exact name of r

November 13, 2008 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2008 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 333-151332 AVENTERRA EXPLORATIONS, INC. (Exact name of regis

August 14, 2008 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2008 OR [ ] TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2008 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 333-151332 AVENTERRA EXPLORATIONS, INC. (Exact name of registrant

May 30, 2008 EX-21.1

SUBSIDIARIES OF THE REGISTRANT

Exhibit 21.1 - Subsidiaries of the Registrant Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT Aventerra Explorations Ltd.

May 30, 2008 EX-3.2

BYLAWS OF AVENTERRA EXPLORATIONS, INC.

Exhibit 3.2 BYLAWS OF AVENTERRA EXPLORATIONS, INC. I. SHAREHOLDER'S MEETING. .01 Annual Meetings. The annual meeting of the shareholders of this Corporation, for the purpose of election of Directors and for such other business as may come before it, shall be held at the registered office of the Corporation, or such other places, either within or without the State of Nevada, as may be designated by

May 30, 2008 EX-3.1

AVENTERRA EXPLORATIONS, INC. ADDITIONAL ARTICLES

Exhibit 3.1 - Articles of Incorporation Exhibit 3.1 ROSS MILLER Filed in the office of Document Number Secretary of State ROSS MILLER 20070135931-71 [SEAL] 206 North Carson Street Ross Miller Filing Date and Time Carson City, Nevada 89701-4299 Secretary of State 2/27/2007 12:20PM (775) 684 5708 State of Nevada Entity Number Website: secretaryofstate.biz E0136282007-6 Articles of Incorporation (PUR

May 30, 2008 S-1

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________ FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AVENTERRA EXPLORATIONS, INC. (Name of small business issuer in its charter) Nevada (State or Other Jurisdicti

aventerras-1.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AVENTERRA EXPLORATIONS, INC. (Name of small business issuer in its charter) Nevada (State or Other Jurisdiction of Organization) AVENTERRA EXPLORATIONS, INC. 2

May 30, 2008 EX-4.1

Number Shares AVENTERRA EXPLORATIONS, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF NEVADA 100,000,000 SHARES COMMON STOCK AUTHORIZED, $0.00001 PAR VALUE CUSIP _______ SEE REVERSE FOR This CERTAIN certifies DEFINITIONS that is the owner of FULLY P

Exhibit 4.1 - Specimen Stock Certificate Exhibit 4.1 Number Shares AVENTERRA EXPLORATIONS, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF NEVADA 100,000,000 SHARES COMMON STOCK AUTHORIZED, $0.00001 PAR VALUE CUSIP SEE REVERSE FOR This CERTAIN certifies DEFINITIONS that is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK OF AVENTERRA EXPLORATIONS, INC. transferable on the books o

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista